Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Blinded, Comparative Effectiveness Study of Fosphenytoin, Valproic Acid, or Levetiracetam in the Emergency Department Treatment of Patients With Benzodiazepine-refractory Status Epilepticus.

NCT01960075 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT01960075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01960075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Blinded, Comparative Effectiveness Study of Fosphenytoin, Valproic Acid, or Levetiracetam in the Emergency Department Treatment of Patients With Benzodiazepine-refractory Status Epilepticus.
Lead sponsor
University of Virginia
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2015
Completion date
May 31, 2019
Enrollment
478 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

benzodiazepine refractory status epilepticus